Clinical pharmacology of daikenchuto assessed by transit analysis using radiopaque markers in patients with colon cancer undergoing open surgery: a multicenter double-blind randomized placebo-controlled study (JFMC39-0902 additional study).
about
Daikenchuto (TU-100) alters murine hepatic and intestinal drug metabolizing enzymes in an in vivo dietary model: effects of gender and withdrawalMeta-analysis of randomized controlled trials on the efficacy of daikenchuto on improving intestinal dysfunction after abdominal surgery.Transition of serum cytokines following pancreaticoduodenectomy: A subsidiary study of JAPAN-PDDaikenchuto (Da-Jian-Zhong-Tang) ameliorates intestinal fibrosis by activating myofibroblast transient receptor potential ankyrin 1 channel
P2860
Clinical pharmacology of daikenchuto assessed by transit analysis using radiopaque markers in patients with colon cancer undergoing open surgery: a multicenter double-blind randomized placebo-controlled study (JFMC39-0902 additional study).
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
Clinical pharmacology of daike ...... JFMC39-0902 additional study).
@en
Clinical pharmacology of daike ...... mized placebo-controlled study
@nl
type
label
Clinical pharmacology of daike ...... JFMC39-0902 additional study).
@en
Clinical pharmacology of daike ...... mized placebo-controlled study
@nl
prefLabel
Clinical pharmacology of daike ...... JFMC39-0902 additional study).
@en
Clinical pharmacology of daike ...... mized placebo-controlled study
@nl
P2093
P2860
P1476
Clinical pharmacology of daike ...... JFMC39-0902 additional study).
@en
P2093
Akira Tsunoda
Hidetoshi Katsuno
Hiroki Ohge
Hiroyoshi Matsuoka
Kazuhiko Yoshioka
Keiji Koda
Koutarou Maeda
Masaki Kitajima
Masatoshi Ohya
Satoshi Morita
P2860
P304
P356
10.1007/S00535-015-1100-1
P577
2015-07-11T00:00:00Z